Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-006759·Basel Medical Group Ltd
Schedule 13G ownership disclosure
BASEL MED GROUP LTD
Ordinary Shares with no par value · CUSIP: G0864B103
Event date: 2025-02-21
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rainforest Capital VCC
Shares: 10,174,579.00 · Class: 54.2%
- Mengli Chen
Shares: 10,174,579.00 · Class: 54.2%
- Keng Leong Fung
Shares: 10,174,579.00 · Class: 54.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-006759
- Form type
- SCHEDULE 13G
- Filer
- Basel Medical Group Ltd
- CIK
- CIK 2004489
- Filed
- Apr 30, 2025
- Reporting period
- Feb 21, 2025
- Description
- Schedule 13G beneficial ownership